# Scientific Award AstraZeneca Foundation in Cancer as a Systemic Disease: Insights on Organ Crosstalk

**Funder:** AstraZeneca Foundation
**Consortium:** No
**Official call:** https://www.fwo.be/en/support-programmes/all-calls/senior-researchersresearch-teams/scientific-award-astrazeneca-foundation-in-cancer-as-a-systemic-disease-insights-on-organ-crosstalk/
**Last verified:** 18 June 2026

## Summary

The AstraZeneca Foundation Scientific Award funds research on cancer as a systemic disease, with emphasis on organ crosstalk mechanisms and their role in tumour progression and treatment response. The call welcomes researchers investigating how interactions between tumour and non-tumour tissues shape cancer biology and therapeutic outcomes.

## Who should apply

- Cancer researchers investigating tumour microenvironment and organ crosstalk
- Researchers with expertise in systemic cancer biology
- Translational or fundamental researchers bridging molecular and whole-organism perspectives
- Applicants working in academic or research institutions

## Key dates

- Applications first listed 12 April 2026; verify current deadline on AstraZeneca Foundation website

## Tips for applicants

- Ground your proposal in specific organ systems and measurable crosstalk mechanisms, vague systemic claims score poorly.
- Emphasise translational relevance: how understanding organ crosstalk could improve drug response prediction or identify new therapeutic targets.
- If your work bridges preclinical and clinical, highlight the patient-centred insight; AstraZeneca Foundation values clinically grounded hypotheses.

## Frequently asked questions

### What is the focus of the AstraZeneca Foundation cancer award?

The award funds research on cancer as a systemic disease, with particular emphasis on understanding organ crosstalk, how interactions between tumour and non-tumour tissues influence disease progression and treatment response.

### Who should apply for the AstraZeneca Foundation Scientific Award?

Cancer researchers working on systemic disease mechanisms, tumour microenvironment, or organ interactions at academic or research institutions.

### Is a consortium required for the AstraZeneca Foundation cancer award?

No, the award does not require a consortium; single-investigator and small team submissions are eligible.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/astrazeneca-foundation-scientific-award-astrazeneca-foundation-in-cancer--2026) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.

**See which EU calls match your profile.** [Preview your matches in 30 seconds, no signup](https://grantsby.eu/demo?ref=llm_grant_md).